Novartis’ new CAR-T drug for leukemia will be costly, Amgen stands by Repatha’s value in PCSK9 cost debate, Ironwood focuses on primary care docs with new gout med, and more - scroll down for the latest news
Embed from Getty Imagesclick here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on device social media
For banking news and anonymous forums, be sure to check out cafebanking.com
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,